vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and Installed Building Products, Inc. (IBP). Click either name above to swap in a different company.
Elanco Animal Health Inc is the larger business by last-quarter revenue ($1.1B vs $747.5M, roughly 1.5× Installed Building Products, Inc.). Installed Building Products, Inc. runs the higher net margin — 10.2% vs -24.1%, a 34.4% gap on every dollar of revenue. On growth, Elanco Animal Health Inc posted the faster year-over-year revenue change (12.2% vs -0.4%). Installed Building Products, Inc. produced more free cash flow last quarter ($49.3M vs $46.0M). Over the past eight quarters, Installed Building Products, Inc.'s revenue compounded faster (3.9% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Installed Building Products, Inc. is a leading US-based provider of professional installation services for building products. Core offerings include insulation, gutters, garage doors, fire protection systems and window treatments, serving residential new construction, repair & remodel, and commercial construction segments across most US regions.
ELAN vs IBP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $747.5M |
| Net Profit | $-276.0M | $76.6M |
| Gross Margin | 51.5% | 35.0% |
| Operating Margin | -22.6% | 14.6% |
| Net Margin | -24.1% | 10.2% |
| Revenue YoY | 12.2% | -0.4% |
| Net Profit YoY | -3350.0% | 14.5% |
| EPS (diluted) | $-0.55 | $2.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $747.5M | ||
| Q3 25 | $1.1B | $778.2M | ||
| Q2 25 | $1.2B | $760.3M | ||
| Q1 25 | $1.2B | $684.8M | ||
| Q4 24 | $1.0B | $750.2M | ||
| Q3 24 | $1.0B | $760.6M | ||
| Q2 24 | $1.2B | $737.6M | ||
| Q1 24 | $1.2B | $692.9M |
| Q4 25 | $-276.0M | $76.6M | ||
| Q3 25 | $-34.0M | $74.4M | ||
| Q2 25 | $11.0M | $69.0M | ||
| Q1 25 | $67.0M | $45.4M | ||
| Q4 24 | $-8.0M | $66.9M | ||
| Q3 24 | $364.0M | $68.6M | ||
| Q2 24 | $-50.0M | $65.2M | ||
| Q1 24 | $32.0M | $55.9M |
| Q4 25 | 51.5% | 35.0% | ||
| Q3 25 | 53.4% | 34.0% | ||
| Q2 25 | 57.5% | 34.2% | ||
| Q1 25 | 57.3% | 32.7% | ||
| Q4 24 | 50.9% | 33.6% | ||
| Q3 24 | 52.2% | 33.8% | ||
| Q2 24 | 58.2% | 34.1% | ||
| Q1 24 | 57.3% | 33.8% |
| Q4 25 | -22.6% | 14.6% | ||
| Q3 25 | -4.4% | 13.7% | ||
| Q2 25 | 2.0% | 13.3% | ||
| Q1 25 | 5.0% | 10.2% | ||
| Q4 24 | -5.0% | 13.1% | ||
| Q3 24 | 54.3% | 13.3% | ||
| Q2 24 | -2.7% | 12.9% | ||
| Q1 24 | 1.0% | 12.7% |
| Q4 25 | -24.1% | 10.2% | ||
| Q3 25 | -3.0% | 9.6% | ||
| Q2 25 | 0.9% | 9.1% | ||
| Q1 25 | 5.6% | 6.6% | ||
| Q4 24 | -0.8% | 8.9% | ||
| Q3 24 | 35.3% | 9.0% | ||
| Q2 24 | -4.2% | 8.8% | ||
| Q1 24 | 2.7% | 8.1% |
| Q4 25 | $-0.55 | $2.81 | ||
| Q3 25 | $-0.07 | $2.74 | ||
| Q2 25 | $0.02 | $2.52 | ||
| Q1 25 | $0.13 | $1.64 | ||
| Q4 24 | $-0.01 | $2.39 | ||
| Q3 24 | $0.73 | $2.44 | ||
| Q2 24 | $-0.10 | $2.30 | ||
| Q1 24 | $0.06 | $1.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $321.9M |
| Total DebtLower is stronger | $3.9B | $886.6M |
| Stockholders' EquityBook value | $6.5B | $709.9M |
| Total Assets | $13.4B | $2.1B |
| Debt / EquityLower = less leverage | 0.60× | 1.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $321.9M | ||
| Q3 25 | $505.0M | $333.3M | ||
| Q2 25 | $539.0M | $305.2M | ||
| Q1 25 | $487.0M | $298.7M | ||
| Q4 24 | $468.0M | $327.6M | ||
| Q3 24 | $490.0M | $406.2M | ||
| Q2 24 | $416.0M | $380.3M | ||
| Q1 24 | $345.0M | $399.9M |
| Q4 25 | $3.9B | $886.6M | ||
| Q3 25 | $4.0B | $880.8M | ||
| Q2 25 | $4.1B | $876.1M | ||
| Q1 25 | $4.4B | $872.4M | ||
| Q4 24 | $4.3B | $874.8M | ||
| Q3 24 | $4.4B | $872.3M | ||
| Q2 24 | $5.7B | $875.8M | ||
| Q1 24 | $5.8B | $875.0M |
| Q4 25 | $6.5B | $709.9M | ||
| Q3 25 | $6.7B | $678.6M | ||
| Q2 25 | $6.8B | $664.5M | ||
| Q1 25 | $6.4B | $660.9M | ||
| Q4 24 | $6.1B | $705.3M | ||
| Q3 24 | $6.5B | $716.4M | ||
| Q2 24 | $5.9B | $685.3M | ||
| Q1 24 | $6.1B | $679.2M |
| Q4 25 | $13.4B | $2.1B | ||
| Q3 25 | $13.6B | $2.1B | ||
| Q2 25 | $13.7B | $2.0B | ||
| Q1 25 | $12.9B | $2.0B | ||
| Q4 24 | $12.6B | $2.1B | ||
| Q3 24 | $13.3B | $2.1B | ||
| Q2 24 | $13.8B | $2.0B | ||
| Q1 24 | $14.0B | $2.0B |
| Q4 25 | 0.60× | 1.25× | ||
| Q3 25 | 0.59× | 1.30× | ||
| Q2 25 | 0.61× | 1.32× | ||
| Q1 25 | 0.69× | 1.32× | ||
| Q4 24 | 0.70× | 1.24× | ||
| Q3 24 | 0.67× | 1.22× | ||
| Q2 24 | 0.96× | 1.28× | ||
| Q1 24 | 0.95× | 1.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $64.9M |
| Free Cash FlowOCF − Capex | $46.0M | $49.3M |
| FCF MarginFCF / Revenue | 4.0% | 6.6% |
| Capex IntensityCapex / Revenue | 5.4% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 0.85× |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $300.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $64.9M | ||
| Q3 25 | $219.0M | $124.0M | ||
| Q2 25 | $237.0M | $90.4M | ||
| Q1 25 | $-4.0M | $92.1M | ||
| Q4 24 | $177.0M | $74.8M | ||
| Q3 24 | $162.0M | $101.4M | ||
| Q2 24 | $200.0M | $79.0M | ||
| Q1 24 | $2.0M | $84.8M |
| Q4 25 | $46.0M | $49.3M | ||
| Q3 25 | $127.0M | $104.8M | ||
| Q2 25 | $180.0M | $74.8M | ||
| Q1 25 | $-69.0M | $71.9M | ||
| Q4 24 | $130.0M | $52.9M | ||
| Q3 24 | $120.0M | $77.3M | ||
| Q2 24 | $166.0M | $58.2M | ||
| Q1 24 | $-22.0M | $63.0M |
| Q4 25 | 4.0% | 6.6% | ||
| Q3 25 | 11.2% | 13.5% | ||
| Q2 25 | 14.5% | 9.8% | ||
| Q1 25 | -5.8% | 10.5% | ||
| Q4 24 | 12.7% | 7.1% | ||
| Q3 24 | 11.7% | 10.2% | ||
| Q2 24 | 14.0% | 7.9% | ||
| Q1 24 | -1.8% | 9.1% |
| Q4 25 | 5.4% | 2.1% | ||
| Q3 25 | 8.1% | 2.5% | ||
| Q2 25 | 4.6% | 2.1% | ||
| Q1 25 | 5.4% | 2.9% | ||
| Q4 24 | 4.6% | 2.9% | ||
| Q3 24 | 4.1% | 3.2% | ||
| Q2 24 | 2.9% | 2.8% | ||
| Q1 24 | 2.0% | 3.1% |
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 1.67× | ||
| Q2 25 | 21.55× | 1.31× | ||
| Q1 25 | -0.06× | 2.03× | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 0.45× | 1.48× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | 0.06× | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
IBP
| Residential New Construction | $488.6M | 65% |
| Other Customer Installation | $67.8M | 9% |
| Shower Doors Shelving And Mirrors | $53.5M | 7% |
| Other Building Products | $47.7M | 6% |
| Fireproofing And Firestopping | $37.6M | 5% |
| Rain Gutters | $31.3M | 4% |
| Window Blinds | $18.0M | 2% |
| Related Party | $6.7M | 1% |
